Skip to content

Application of cyclopofol in patients undergoing operation under general anesthesia

Application of cyclopofol in patients undergoing operation under general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064506
Enrollment
Unknown
Registered
2022-10-10
Start date
2022-10-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia

Interventions

C1:Cyclopofol 0.4 mg/kg was injected intravenously
C2:Cyclopofol 0.5 mg/kg was injected intravenously
C3:Cyclopofol 0.6 mg/kg was injected intravenously
P:Propofol 2 mg/kg was injected intravenously

Sponsors

Sir Run Run Hospital Affiliated to Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Patients receiving painless gastroscopy, regardless of gender, aged 18-64 years, BMI 18-30 kg/m2, ASA I or II; 2. Volunteer to participate in this research, and voluntarily sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Previously allergic to cyclopofol and propofol; 2. Combined with mental illness, abnormal liver and kidney function; 3. History of drug or alcohol abuse; 4. Severe cardiopulmonary disease; 5. Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Number of successful sedation cases;The number of cases supplemented with cyclopofol or propofol;Wake up of time;Time of departure from hospital;Heart rate;Systolic blood pressure;Diastolic blood pressure;Pulse oxygen saturation;Pulse oxygen saturation;

Secondary

MeasureTime frame
Adverse reactions;

Countries

China

Contacts

Public ContactWenbo Liang

Sir Run Run Hospital Affiliated to Nanjing Medical University

496568933@qq.com+86 15250991145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026